The novel treatment of the medication represents a major development in the management of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects two pathways – GLP-1 and GIP – leading to https://tirzepatide-peptide840803.acidblog.net/73308826/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment